ConsultationwhatsappNCT02605317
Use of WhatsApp for Communication Between Consulting Physicians and the Emergency Physicians
An observational study of Consultation, run by Adiyaman University Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to determinate outcomes of WhatsApp Messenger (a messaging program for smart phones) usage for Communication Between Consulting Physicians and the Emergency Physicians. Read more about this study
- Who is it for?
- Ages 19 to 70 years
- Conditions the study is for
- Consultation
- What is being tested?
- How many people
- 500 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- Jan 2014to Aug 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients who were consulted with whatsApp and who were admitted to Emergency Department.
Who may be able to join
- Age≥18 years
Who cannot join
- Patients who were not known the reason of admission to Emergency Service
- Patients who were not determined consulting Physicians' arrival duration to emergency department
- Patients who were not known the outcomes of consultation
- Patients transferred other hospitals from Emergency Service
- Patients who were not determined the time of consultation call
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Adiyaman University Research Hospital
Adıyaman, Central, 02000
About this study
Official title: Use of whatsApp Messenger (a Messaging Program for Smart Phones) in Communication Between Consulting Physicians and the Emergency Physicians: A Retrospective Observational Study
The aim of this study is to determinate outcomes of WhatsApp Messenger (a messaging program for smart phones) usage for Communication Between Consulting Physicians and the Emergency Physicians.
Read the detailed description
Effective communication between consulting physicians and the emergency physicians is critical for patients in the emergency department. WhatsApp Messenger (a messaging program for smart phones), is the most commonly used for communication in at present. WhatsApp Messenger is the most globally popular messaging application. Also, it has been started to be used for communication in healthcare. The aim of this study is to determinate outcomes of WhatsApp Messenger usage for communication between consulting and the emergency physicians.
- Conditions
- Consultation
- Being tested
- Keywords
- Emergency Physicians, Consulting Physicians, WhatsApp
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
WhatsAppOther
Also called A smart phone application
Consultations used WhatsApp Messenger
What is being measured
The primary outcome is the main question the study is designed to answer.
Examine outcomes of consultations generated with WhatsApp from data obtained by the recording data in the WhatsApp messenger program
Patients' demographic data (date of birth/age and gender), date of consultation, time of consultation calls, patients' reason of admission to Emergency Service, consulting Physicians' arrival duration to emergency department, outcomes of consultation, date of discharge from Emergency Service were noted by an assistant blinded to the study.
Measured: six month
Secondary outcomes (1)
Examine demographic data in consultations generated with WhatsApp from data obtained by the recording data in the WhatsApp messenger program
Patients' demographic data (date of birth/age and gender), date of consultation and patients' data such as imagine, voice, writing and laboratory results sent with WhatsApp were noted by an assistant blinded to the study.
Measured: six month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Nov 2015 (estimated)
- Study startJan 2014
- Primary completionJul 2015
- Study completionAug 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for ConsultationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 500 participants (actual)
Sponsor and investigators
- Lead sponsor
- Adiyaman University Research Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Umut Gulacti, Adiyaman University Research Hospital
- Investigators
- Umut Gulacti, Principal investigator, Adiyaman University of Medical Faculty
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02605317
- Sponsor's protocol ID
- ADYU
- Acronym
- Status last verified
- Jan 2016
- First submitted
- 11 Nov 2015
- Last updated
- 14 Jan 2016
- Results posted
- No
- Data monitoring committee
- No
Publications
Astarcioglu MA, Sen T, Kilit C, Durmus HI, Gozubuyuk G, Kalcik M, Karakoyun S, Yesin M, Zencirkiran Agus H, Amasyali B. Time-to-reperfusion in STEMI undergoing interhospital transfer using smartphone and WhatsApp messenger. Am J Emerg Med. 2015 Oct;33(10):1382-4. doi: 10.1016/j.ajem.2015.07.029. Epub 2015 Jul 31.
PubMed 26299691Montag C, Blaszkiewicz K, Sariyska R, Lachmann B, Andone I, Trendafilov B, Eibes M, Markowetz A. Smartphone usage in the 21st century: who is active on WhatsApp? BMC Res Notes. 2015 Aug 4;8:331. doi: 10.1186/s13104-015-1280-z.
PubMed 26238512Veneroni L, Ferrari A, Acerra S, Massimino M, Clerici CA. [Considerations on the use of WhatsApp in physician-patient communication and relationship]. Recenti Prog Med. 2015 Jul;106(7):331-6. doi: 10.1701/1940.21090. Italian.
PubMed 26228724Drake TM, Claireaux HA, Khatri C, Chapman SJ. WhatsApp with patient data transmitted via instant messaging? Am J Surg. 2016 Jan;211(1):300-1. doi: 10.1016/j.amjsurg.2015.04.004. Epub 2015 May 28. No abstract available.
PubMed 26092444
Study at a glance
From the registry record, last updated by the sponsor on 14 Jan 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use of whatsApp Messenger (a Messaging Program for Smart Phones) in Communication Between Consulting Physicians and the Emergency Physicians: A Retrospective Observational Study
- ClinicalTrials.gov ID
- NCT02605317
- Acronym / sponsor ID
- whatsapp / ADYU
- Conditions
- Consultation
- Keywords
- Emergency Physicians, Consulting Physicians, WhatsApp
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 500 participants (actual)
- Lead sponsor
- Adiyaman University Research HospitalUniversity, hospital or other
- Study start
- Jan 2014
- Primary completion
- Jul 2015 (actual)
- Study completion
- Aug 2015 (actual)
- First posted
- 16 Nov 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to determinate outcomes of WhatsApp Messenger (a messaging program for smart phones) usage for Communication Between Consulting Physicians and the Emergency Physicians.
Detailed description
Effective communication between consulting physicians and the emergency physicians is critical for patients in the emergency department. WhatsApp Messenger (a messaging program for smart phones), is the most commonly used for communication in at present. WhatsApp Messenger is the most globally popular messaging application. Also, it has been started to be used for communication in healthcare. The aim of this study is to determinate outcomes of WhatsApp Messenger usage for communication between consulting and the emergency physicians.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 19 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients who were consulted with whatsApp and who were admitted to Emergency Department.
Key inclusion criteria (1 listed)
- Age≥18 years
Key exclusion criteria (5 listed)
- Patients who were not known the reason of admission to Emergency Service
- Patients who were not determined consulting Physicians' arrival duration to emergency department
- Patients who were not known the outcomes of consultation
- Patients transferred other hospitals from Emergency Service
- Patients who were not determined the time of consultation call
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| WhatsAppAlso: A smart phone applicationConsultations used WhatsApp Messenger | Other | – |
Primary outcome
Examine outcomes of consultations generated with WhatsApp from data obtained by the recording data in the WhatsApp messenger program
Time frame: six month
Patients' demographic data (date of birth/age and gender), date of consultation, time of consultation calls, patients' reason of admission to Emergency Service, consulting Physicians' arrival duration to emergency department, outcomes of consultation, date of discharge from Emergency Service were noted by an assistant blinded to the study.
1 secondary outcome
Examine demographic data in consultations generated with WhatsApp from data obtained by the recording data in the WhatsApp messenger program
Time frame: six month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jan 2016.
- Background: PubMed 26299691Astarcioglu MA, Sen T, Kilit C, Durmus HI, Gozubuyuk G, Kalcik M, Karakoyun S, Yesin M, Zencirkiran Agus H, Amasyali B. Time-to-reperfusion in STEMI undergoing interhospital transfer using smartphone and WhatsApp messenger. Am J Emerg Med. 2015 Oct;33(10):1382-4. doi: 10.1016/j.ajem.2015.07.029. Epub 2015 Jul 31.
- Background: PubMed 26238512Montag C, Blaszkiewicz K, Sariyska R, Lachmann B, Andone I, Trendafilov B, Eibes M, Markowetz A. Smartphone usage in the 21st century: who is active on WhatsApp? BMC Res Notes. 2015 Aug 4;8:331. doi: 10.1186/s13104-015-1280-z.
- Background: PubMed 26228724Veneroni L, Ferrari A, Acerra S, Massimino M, Clerici CA. [Considerations on the use of WhatsApp in physician-patient communication and relationship]. Recenti Prog Med. 2015 Jul;106(7):331-6. doi: 10.1701/1940.21090. Italian.
- Background: PubMed 26092444Drake TM, Claireaux HA, Khatri C, Chapman SJ. WhatsApp with patient data transmitted via instant messaging? Am J Surg. 2016 Jan;211(1):300-1. doi: 10.1016/j.amjsurg.2015.04.004. Epub 2015 May 28. No abstract available.
Related trials for Consultation
Recruiting
Advancing Skills Through Consultation, Education, and Novel Technologies
PTSD - Post Traumatic Stress Disorder
Recruiting
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
Breast Cancer, Cancer of the Breast
Recruiting
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
Breast Cancer
Recruiting
Effects of Medisinstart for Type 2 Diabetes
Type 2 Diabetes
RecruitingObservational study
Detection of Health Risk Situations in the Anesthesia Consultation.
Surgical Procedures, Operative
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Umut Gulacti principal investigator
Adiyaman University of Medical Faculty
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Consultation, run by Adiyaman University Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Examine outcomes of consultations generated with WhatsApp from data obtained by the recording data in the WhatsApp messenger program (time frame: six month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02605317, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2016.